Investigation of the effects of platelet-activating factor (PAF) on ion transport and prostaglandin synthesis in human colonic mucosa in vitro

被引:16
作者
Borman, RA [1 ]
Jewell, R [1 ]
Hillier, K [1 ]
机构
[1] Univ Southampton, Sch Med, Clin Pharmacol Grp, Southampton SO16 7PX, Hants, England
关键词
platelet-activating factor (PAF); human colon; ion transport; prostaglandin synthesis;
D O I
10.1038/sj.bjp.0701602
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 We have investigated the effects of platelet-activating factor (PAF), an endogenous mediator of inflammation, on ion transport and prostaglandin synthesis in the human isolated colon. 2 Application of PAF to the serosal surface of human colonic mucosa induced a marked, concentration-dependent increase in ion transport. Mucosal application was without effect. 3 The secretory response to PAF was significantly inhibited by prior application of a specific PAF receptor antagonist WEB 2170, indicating that the response is dependent on PAF receptor activation. 4 The response to PAF was attenuated by prior application of indomethacin or piroxicam, implicating products of the cyclo-oxygenase pathway in the response. 5 The response to PAF was attenuated by the loop diuretic bumetanide, indicating an involvement of chloride ion secretion in the response. 6 Addition of PAF to the serosal surface induced a significant increase in serosal prostaglandin E-2 (PGE(2)), but not 6-oxo-PGF(1 alpha) release. There was no effect on mucosal application of PAF. 7 In summary, we have shown that PAF is a potent secretagogue in isolated preparations of human colon and that the response is dependent on a specific PAF receptor, cyclo-oxygenase products and bumetanide-sensitive chloride ion transport.
引用
收藏
页码:231 / 236
页数:6
相关论文
共 24 条
[1]   BIOSYNTHESIS OF PLATELET-ACTIVATING-FACTOR IN NORMAL AND INFLAMED HUMAN COLON MUCOSA - EVIDENCE FOR THE INVOLVEMENT OF THE PATHWAY OF PLATELET-ACTIVATING-FACTOR SYNTHESIS DE-NOVO IN INFLAMMATORY BOWEL-DISEASE [J].
APPLEYARD, CB ;
HILLIER, K .
CLINICAL SCIENCE, 1995, 88 (06) :713-717
[2]   CATABOLISM OF PLATELET-ACTIVATING-FACTOR BY HUMAN COLONIC MUCOSA - CALCIUM DEPENDENCE OF THE CATABOLIZING ENZYMES [J].
APPLEYARD, CB ;
HILLIER, K .
BIOCHEMICAL PHARMACOLOGY, 1992, 43 (12) :2503-2509
[3]   IMMUNE-SYSTEM CONTROL OF RAT AND RABBIT COLONIC ELECTROLYTE TRANSPORT - ROLE OF PROSTAGLANDINS AND ENTERIC NERVOUS-SYSTEM [J].
BERN, MJ ;
STURBAUM, CW ;
KARAYALCIN, SS ;
BERSCHNEIDER, HM ;
WACHSMAN, JT ;
POWELL, DW .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (06) :1810-1820
[4]  
Borman RA, 1997, BRIT J PHARMACOL, V120, pP188
[5]   EVIDENCE FOR THE INVOLVEMENT OF A 5-HT(4) RECEPTOR IN THE SECRETORY RESPONSE OF HUMAN SMALL-INTESTINE TO 5-HT [J].
BORMAN, RA ;
BURLEIGH, DE .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (03) :927-928
[6]   PLATELET ACTIVATING FACTOR IS A POTENT COLONIC SECRETAGOGUE WITH ACTIONS INDEPENDENT OF SPECIFIC PAF RECEPTORS [J].
BUCKLEY, TL ;
HOULT, JRS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 163 (2-3) :275-283
[7]  
CAMUSSI G, 1987, NEW HORIZONS PLATELE, P245
[8]   MODIFICATION OF UPPER GASTROINTESTINAL PROSTAGLANDIN SYNTHESIS BY DIETARY FATTY-ACIDS [J].
DELAHUNT, MN ;
HILLIER, K ;
JEWELL, R .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1988, 35 (04) :597-608
[9]   INTESTINAL EPITHELIAL-CELLS CONTRIBUTE TO THE ENHANCED GENERATION OF PLATELET-ACTIVATING-FACTOR IN ULCERATIVE-COLITIS [J].
FERRARIS, L ;
KARMELI, F ;
ELIAKIM, R ;
KLEIN, J ;
FIOCCHI, C ;
RACHMILEWITZ, D .
GUT, 1993, 34 (05) :665-668
[10]   ROLE OF PLATELET-ACTIVATING-FACTOR IN THE INFLAMMATORY AND SECRETORY EFFECTS OF CLOSTRIDIUM-DIFFICILE TOXIN-A [J].
FONTELES, M ;
FANG, GD ;
THIELMAN, NM ;
YOTSEFF, PS ;
GUERRANT, RL .
JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING, 1995, 11 (02) :133-143